Targeting protein arginine methyltransferase 5 sensitizes glioblastoma to trametinibYeshavanth Banasavadi‐Siddegowda, Balveen Kaur, Sarah Rivas et al.|Neuro-Oncology Advances|2022Cited by 13
DDRE-26. INHIBITION OF PRMT5 SENSITIZES GLIOBLASTOMA MODELS TO TRAMETINIB TREATMENTYesh Banasavadi, Balveen Kaur, Sriya Namagiri et al.|Neuro-Oncology|2021Cited by 0